“PHARMACOKINETICS OF SECOND LINE ANTI-TB DRUG (LEVOFLOXACIN) IN MDR-TB PATIENTS”. 2019. Scholar: National School of Leadership 8 (2.2). https://jconsortium.com/index.php/scholar/article/view/93.